Moved from domestic to international toxic funding. Past 9 months unable to capitalize on anything not even revenue. It's turning into the Joe "blooper" show. Clear indication "ego" plays a big roll. No support due to credibility/trust of leadership. Don't expect 2020 NGIO/GNBT listing ....another year with missed targets....appears to be an ongoing issue. Not frustrated or bashing just the facts. BOD just going along for the ride ..... unable or willing to make adjustments. Even with financial success it will continue to be a high-risk investment due to the blurry vision and unable to execute !! Money talks BS walks and the pps tells the story . Covid vaccine excitement slowing down due to billion+ in production. No worries ....we are working on swine flu but be patient ....it will take some time but highly confident !! It's all good and exciting times ahead.
(2)
(1)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links